Opendata, web and dolomites

SOS Jelly

An advanced biological remedy against jellyfish stings

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SOS Jelly project word cloud

Explore the words cloud of the SOS Jelly project. It provides you a very rough idea of what is the project "SOS Jelly" about.

licensing    time    ingredient    local    constitute    belong    completely    generally    human    intends    death    bio    biosynthetic    touch    gel    commercialization    sos    losses    manufacturing    350    toxicity    annually    entry    generation    tourism    ancestors    preservatives    symptoms    millions    jellyfish    protect    life    france    million    anemones    ed    systemic    biomimetic    industries    black    compliance    transfer    fish    manufacturers    industrial    invasion    sunscreen    formulate    clownfish    stiffness    minutes    contact    toxins    comb    dermatitis    jelly    allergic    sea    poison    skin    film    public    technological    immune    florida    cnidarian    threat    laboratory    people    sosjelly    suitable    proliferations    feasibility    formulation    stung    abich    threatening    mimetic    regulation    stings    lineage    commercial    foreseen    anomalous    pain    swelling    itching    seas    hours    severe    types    medusa    molecules    mediterranean    thanks    150    fishing    necrosis    molecule    envenomation    mix    200    italy    parties    health    market    issue    first    creams    kill    few    oedema    volume    sometimes   

Project "SOS Jelly" data sheet

The following table provides information about the project.

Coordinator
ABICH SRL 

Organization address
address: VIA QUARANTADUE MARTIRI 213/B
city: FONDOTOCE VB
postcode: 28924
website: www.abich.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website http://www.abich.it
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.4. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-06-01   to  2016-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ABICH SRL IT (FONDOTOCE VB) coordinator 50˙000.00

Map

 Project objective

In recent years anomalous proliferations of jellyfish are increasing in all seas: human envenomation by jellyfish toxins produce immediate toxicity (from minutes to few hours), with allergic responses, generally determining local symptoms (dermatitis, oedema and swelling, itching, stiffness, necrosis, pain) or more severe systemic effects. These can also be life threatening and, sometimes, bring to death. It has been estimated there are 150 million jellyfish stings a year, about 200,000 people are annually stung by jellyfish in the only Florida. $350 million in losses to the Black Sea’s fishing and tourism industries resulted from the invasion of the comb jelly into the Black Sea. Therefore, beyond a public health issue, jellyfish also constitute a threat to tourism. Sea anemones can kill other fish that touch them; clownfish is therefore immune to the poison, thanks to generation of a biomimetic film on the fish skin. Toxins in the different types of Cnidarian (e.g. medusa and anemones) are similar, as they developed from common ancestors and belong to the same lineage. The project SOSJelly intends to evaluate the feasibility of the development, manufacturing method, technological transfer and industrial scale-up and to third parties manufacturers, and licensing for commercialization of a completely new biosynthetic molecule or mix of molecules, with bio-mimetic properties, for the first time, able to protect human skin from the jellyfish contact effects. Furthermore, ABICH laboratory will formulate creams and gel without preservatives at all, suitable for allergic people. At the end of the Phase I, a pre-commercial advanced SOS Jelly “package” (ingredient, formulation, laboratory test, regulation compliance, etc.) will be offered to manufacturers of sunscreen products. Target market is a high volume and growing market (millions of people, only in Europe); a first entry in Mediterranean market is foreseen (France and Italy, as the main market).

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SOS JELLY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SOS JELLY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.4.;H2020-EU.2.3.1.)

FlexiBiome (2018)

Next Generation Microbiome Platform

Read More  

SINUSLIGHT (2018)

Laser-spectroscopic sensing device for diagnostic assessment of sinusitis

Read More  

SEQURE (2018)

Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer

Read More